Sponsor Pipeline

Corestemchemon, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07595965 Evaluate the Safety and Tolerability of CE211NS21 in Patients With AQP4-IgG-positive… Neuromyelitis Optica Spectrum Disorder Relapse Not Yet Recruiting
Get alerts when Corestemchemon, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free